4.4 Article

Bedside monitoring of blood β-hydroxybutyrate levels in the management of diabetic ketoacidosis in children

Journal

DIABETES TECHNOLOGY & THERAPEUTICS
Volume 8, Issue 6, Pages 671-676

Publisher

MARY ANN LIEBERT, INC
DOI: 10.1089/dia.2006.8.671

Keywords

-

Funding

  1. NCRR NIH HHS [M01RR00069] Funding Source: Medline
  2. NIDDK NIH HHS [P30DK57516] Funding Source: Medline

Ask authors/readers for more resources

Introduction: Diabetic ketoacidosis (DKA) affects many children with type I diabetes. Insulin treatment of DKA is traditionally guided by changes in the blood glucose levels and blood gases, whereas beta-hydroxybutyrate (beta-OHB)-the main ketoacid causing acidosis-is rarely measured. The purpose of this study was to evaluate if bedside monitoring of blood beta-OHB levels can simplify management of DKA through elimination of superfluous laboratory monitoring. Methods: Our emergency department treated 68 children with DKA using a standard protocol with monitoring of venous pH, partial pressure Of CO2 (pCO(2)), bicarbonate, glucose, blood urea nitrogen, and electrolytes (two to 10 time points per patient). Venous beta-OHB levels were measured using the Precision Xtra(TM) meter (MediSense /Abbott Diabetes Care, Abbott Park, IL) and, on duplicate batched serum samples, using a reference laboratory method (Cobas Mira Plus; Roche Diagnostics, Indianapolis, IN). Correlations between bedside meter beta-OHB and other parameters were evaluated in a series of general linear models with a time series covariance structure fit using spatial power law. Results: The bedside meter beta-OHB levels were significantly correlated with pH (r = -0.63; P < 0.0001), bicarbonate (r = -0.74; P < 0.0001), and PCO2 (r = -0.55; P < 0.0001) at all points of measurement during the treatment (unadjusted Pearson correlations). The pH, bicarbonate, and pCO(2) were entered into separate time series analysis models with treatment duration as a measure of time. The results confirmed that bedside levels of beta-OHB correlated very closely with time-dependent levels of venous pH, bicarbonate, and pCO(2). Good agreement between the two methods of beta-OHB measurement (r = 0.92; P < 0.0001) was confirmed using the Bland-Altman plot analysis. Conclusions: The Precision Xtra accurately measures blood beta-OHB levels, particularly at lower levels. While the initial measurement of pH and/or bicarbonates is warranted, real-time,beta-OHB levels may replace repeat laboratory measurement of these parameters in the management of DKA. Future studies should evaluate safety and cost-effectiveness of such simplified DKA treatment protocol.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available